At a glance
- Originator Meiji Seika Kaisha
- Class Antibacterials; Carbapenems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gram-positive infections
Most Recent Events
- 19 Dec 2002 No development reported - Preclinical for Gram-positive infections in Japan (unspecified route)
- 26 Sep 2000 Preclinical development for Gram-positive infections in Japan (Unknown route)